Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins… - European Respiratory …, 2016 - Eur Respiratory Soc
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins… - … respiratory review: an …, 2016 - pubmed.ncbi.nlm.nih.gov
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
[PDF][PDF] Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins, AA Cruz - 2016 - scholar.archive.org
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
[PDF][PDF] Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins, AA Cruz - 2016 - cyberleninka.org
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
[HTML][HTML] Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins… - European Respiratory …, 2016 - Eur Respiratory Soc
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins… - European …, 2016 - portal.findresearcher.sdu.dk
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
[HTML][HTML] Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins… - European Respiratory …, 2016 - ncbi.nlm.nih.gov
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins… - … Respiratory Review: an …, 2016 - europepmc.org
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
[PDF][PDF] Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
WW Busse, R Dahl, C Jenkins, AA Cruz - 2016 - core.ac.uk
Asthma is a chronic inflammatory disorder of the airways that is a major global burden on
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …
both individuals and healthcare systems. Despite guideline-directed treatment, a significant …